The most common side-effects of the medicine are gastrointestinal such as nausea, diarrhoea, constipation and vomiting
Hyperactivity, tremors, and increased heart rate C
The observed reduction in legal blindness among GLP-1 RA users may be attributed to the drug classs systemic vascular and metabolic benefits, which could mitigate several sight-threatening complications of diabetes
The most common include nausea, vomiting, diarrhea, constipation, abdominal discomfort, and reduced appetite
To manage edema, watch your fluid intake and adjust IGF-1 LR3 dosage if needed
Given the steep costs and high demand for these drugs, employers and insurers may continue to impose more restrictive eligibility standards for coverage than the clinical indications set by the Food and Drug Administration